These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 38436892)
21. Functional analysis of single cells identifies a rare subset of circulating tumor cells with malignant traits. Yao X; Choudhury AD; Yamanaka YJ; Adalsteinsson VA; Gierahn TM; Williamson CA; Lamb CR; Taplin ME; Nakabayashi M; Chabot MS; Li T; Lee GS; Boehm JS; Kantoff PW; Hahn WC; Wittrup KD; Love JC Integr Biol (Camb); 2014 Apr; 6(4):388-98. PubMed ID: 24522233 [TBL] [Abstract][Full Text] [Related]
22. Fluid shear stress regulates the survival of circulating tumor cells via nuclear expansion. Xu Z; Li K; Xin Y; Tang K; Yang M; Wang G; Tan Y J Cell Sci; 2022 May; 135(10):. PubMed ID: 35510498 [TBL] [Abstract][Full Text] [Related]
23. Heterogeneity of Circulating Tumor Cells in Breast Cancer: Identifying Metastatic Seeds. Menyailo ME; Tretyakova MS; Denisov EV Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32121639 [TBL] [Abstract][Full Text] [Related]
24. Jinfukang regulates integrin/Src pathway and anoikis mediating circulating lung cancer cells migration. Que ZJ; Yang Y; Liu HT; Shang-Guan WJ; Yu P; Zhu LH; Li HG; Liu HM; Tian JH J Ethnopharmacol; 2021 Mar; 267():113473. PubMed ID: 33068649 [TBL] [Abstract][Full Text] [Related]
25. Beyond Enumeration: Functional and Computational Analysis of Circulating Tumor Cells to Investigate Cancer Metastasis. Castro-Giner F; Scheidmann MC; Aceto N Front Med (Lausanne); 2018; 5():34. PubMed ID: 29520361 [TBL] [Abstract][Full Text] [Related]
26. Research progress on the multi-omics and survival status of circulating tumor cells. Xie Q; Liu S; Zhang S; Liao L; Xiao Z; Wang S; Zhang P Clin Exp Med; 2024 Mar; 24(1):49. PubMed ID: 38427120 [TBL] [Abstract][Full Text] [Related]
27. High Shear Stresses under Exercise Condition Destroy Circulating Tumor Cells in a Microfluidic System. Regmi S; Fu A; Luo KQ Sci Rep; 2017 Jan; 7():39975. PubMed ID: 28054593 [TBL] [Abstract][Full Text] [Related]
28. Ex-vivo characterization of circulating colon cancer cells distinguished in stem and differentiated subset provides useful biomarker for personalized metastatic risk assessment. Malara N; Trunzo V; Foresta U; Amodio N; De Vitis S; Roveda L; Fava M; Coluccio M; Macrì R; Di Vito A; Costa N; Mignogna C; Britti D; Palma E; Mollace V J Transl Med; 2016 May; 14(1):133. PubMed ID: 27176720 [TBL] [Abstract][Full Text] [Related]
29. Fluid Shear Stress Induces EMT of Circulating Tumor Cells via JNK Signaling in Favor of Their Survival during Hematogenous Dissemination. Xin Y; Li K; Yang M; Tan Y Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143160 [TBL] [Abstract][Full Text] [Related]
30. EMT, CTCs and CSCs in tumor relapse and drug-resistance. Mitra A; Mishra L; Li S Oncotarget; 2015 May; 6(13):10697-711. PubMed ID: 25986923 [TBL] [Abstract][Full Text] [Related]
31. Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma. Sun YF; Guo W; Xu Y; Shi YH; Gong ZJ; Ji Y; Du M; Zhang X; Hu B; Huang A; Chen GG; Lai PBS; Cao Y; Qiu SJ; Zhou J; Yang XR; Fan J Clin Cancer Res; 2018 Feb; 24(3):547-559. PubMed ID: 29070526 [No Abstract] [Full Text] [Related]
32. Molecular characterization of circulating tumor cells-from bench to bedside. Li Y; Wu S; Bai F Semin Cell Dev Biol; 2018 Mar; 75():88-97. PubMed ID: 28899718 [TBL] [Abstract][Full Text] [Related]
33. Circulating tumor cell-derived preclinical models: current status and future perspectives. Kahounová Z; Pícková M; Drápela S; Bouchal J; Szczyrbová E; Navrátil J; Souček K Cell Death Dis; 2023 Aug; 14(8):530. PubMed ID: 37591867 [TBL] [Abstract][Full Text] [Related]
34. Single-Cell Molecular Profiling of Head and Neck Squamous Cell Carcinoma Reveals Five Dysregulated Signaling Pathways Associated With Circulating Tumor Cells. Stucky A; Viet CT; Aouizerat BE; Ye Y; Doan C; Mundluru T; Sedhiazadeh P; Sinha UK; Chen X; Zhang X; Li SC; Cai J; Zhong JF Cancer Control; 2024; 31():10732748241251571. PubMed ID: 38869038 [TBL] [Abstract][Full Text] [Related]
36. Exploiting the metabolic vulnerability of circulating tumour cells. Merteroglu M; Santoro MM Trends Cancer; 2024 Jun; 10(6):541-556. PubMed ID: 38580535 [TBL] [Abstract][Full Text] [Related]
37. The biological and clinical importance of epithelial-mesenchymal transition in circulating tumor cells. Liu H; Zhang X; Li J; Sun B; Qian H; Yin Z J Cancer Res Clin Oncol; 2015 Feb; 141(2):189-201. PubMed ID: 24965746 [TBL] [Abstract][Full Text] [Related]
38. Shear stress promotes anoikis resistance of cancer cells via caveolin-1-dependent extrinsic and intrinsic apoptotic pathways. Li S; Chen Y; Zhang Y; Jiang X; Jiang Y; Qin X; Yang H; Wu C; Liu Y J Cell Physiol; 2019 Apr; 234(4):3730-3743. PubMed ID: 30171601 [TBL] [Abstract][Full Text] [Related]
39. Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis. Sharma U; Medina-Saenz K; Miller PC; Troness B; Spartz A; Sandoval-Leon A; Parke DN; Seagroves TN; Lippman ME; El-Ashry D Breast Cancer Res Treat; 2021 Aug; 189(1):63-80. PubMed ID: 34216317 [TBL] [Abstract][Full Text] [Related]
40. Circulating and disseminated tumor cells: harbingers or initiators of metastasis? Dasgupta A; Lim AR; Ghajar CM Mol Oncol; 2017 Jan; 11(1):40-61. PubMed ID: 28085223 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]